Open Access Open Access  Restricted Access Subscription Access

Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification


Affiliations
1 Departments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
2 Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
 

Becton Dickinson Phoenix Yeast ID Panel was compared to the Remel RapID Yeast Plus System using 150 recent clinical yeast isolates and the API 20C AUX system to resolve discrepant results.The concordance rate between the Yeast ID Panel and the RapID Yeast Plus System (without arbitration) was 93.3% with 97.3% (146/150) and 95.3% (143/150) of the isolates correctly identified by the Becton Dickinson Phoenix and the Remel RapID, respectively, with arbitration.
User
Notifications
Font Size

Abstract Views: 94

PDF Views: 0




  • Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification

Abstract Views: 94  |  PDF Views: 0

Authors

Michelle L. Grant
Departments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
Shobha Parajuli
Departments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
Raquel Deleon-Gonsalves
Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
Raghava Potula
Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States
Allan L. Truant
Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, United States

Abstract


Becton Dickinson Phoenix Yeast ID Panel was compared to the Remel RapID Yeast Plus System using 150 recent clinical yeast isolates and the API 20C AUX system to resolve discrepant results.The concordance rate between the Yeast ID Panel and the RapID Yeast Plus System (without arbitration) was 93.3% with 97.3% (146/150) and 95.3% (143/150) of the isolates correctly identified by the Becton Dickinson Phoenix and the Remel RapID, respectively, with arbitration.